Fingerprint
Dive into the research topics of 'Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC
Scott J. Antonia, Ani Balmanoukian, Julie Brahmer, Sai Hong I. Ou, Matthew D. Hellmann, Sang We Kim, Myung Ju Ahn, Dong Wan Kim, Martin Gutierrez, Stephen V. Liu, Patrick Schöffski, Dirk Jäger, Rahima Jamal, Guy Jerusalem, Jose Lutzky, John Nemunaitis, Luana Calabrò, Jared Weiss, Shirish Gadgeel, Jaishree Bhosle
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations